BRCA2 and prostate carcinoma: In the BRCA2 gene, a prostate cancer cluster region (PCCR) has been identified, in which the oligonucleotide/oligosaccharide- binding domain 1 (OB1) and Tower domain 2 (OB2) correlated with the highest risk of prostate cancer [102].